Optional Non-CME Satellite Presentations
Friday, January 16 - Lunch session
12:15 – 1:00 PM EST
Discover the Combined Power of RYBREVANT FASPRO™ + LAZCLUZE® in EGFR+* Locally Advanced or mNSCLC
Mahadi Baig, MD, MHCM
Vice President
Head, Solid Tumors
US Medical Affairs
Johnson & Johnson
Location: Hemisphere Dancer Room, 9th Floor
View the invitation hereThis program is developed and offered by Johnson & Johnson.
Saturday, January 17 - Breakfast session
7:00 – 7:45 AM EST
Head-to-Head Overall Survival in mCSPC: A Review of Real-World Evidence
Dr. Mohit Narang
Medical Oncologist
Location: Hemisphere Dancer Room, 9th Floor
View the invitation hereThis program is developed and offered by Johnson & Johnson.
Saturday, January 17 - Lunch session
12:30 - 1:15 PM EST
Extensive Stage Small Cell Lung Cancer (ES-SCLC) and IMDELLTRA® (tarlatamab-dlle): The First and Only DLL3-Targeting Bispecific T-cell Engager (BiTE®) Therapy for 2L ES-SCLC
Wade Iams, MD
Medical Oncology, Tennessee Oncology
Elliston Place Plaza – Medical Oncology & Hematology
Nashville – Saint Thomas West Clinic
Location: Hemisphere Dancer Room, 9th Floor
View the invitation hereThis program is developed and offered by Amgen.
Sunday, January 18 - Breakfast session
7:00 – 7:45 AM EST
Precision Medicine in Practice: Clinical Utility of Circulating Tumor DNA Testing for Decision-Making
Dr. Steven Sorscher
Associate Medical Director, GI and Medical Oncology
Natera
Location: Hemisphere Dancer Room, 9th Floor
View the invitation hereThis program is developed and offered by Natera.
These programs are developed and offered by industry supporters. They are not official programs of Cleveland Clinic.